Ramón Bover

600 total citations
30 papers, 275 citations indexed

About

Ramón Bover is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ramón Bover has authored 30 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Ramón Bover's work include Heart Failure Treatment and Management (17 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Ramón Bover is often cited by papers focused on Heart Failure Treatment and Management (17 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiovascular Function and Risk Factors (7 papers). Ramón Bover collaborates with scholars based in Spain, Germany and United Kingdom. Ramón Bover's co-authors include Ana María Pérez García, Manuel Martínez‐Sellés, Lourdes Vicent, Cristina Fernández, Francisco Pérez-Gómez, Birna Bjarnason‐Wehrens, J.A. Iriarte, S Glöggler, Cecilia Vera‐Muñoz and Dario Salvi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Ramón Bover

25 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramón Bover Spain 9 231 30 30 28 22 30 275
Megan M. Streur United States 12 332 1.4× 19 0.6× 38 1.3× 15 0.5× 30 1.4× 22 418
Pieter Koopman Belgium 11 468 2.0× 24 0.8× 20 0.7× 14 0.5× 28 1.3× 29 536
Leonard Sheung-Wai Li China 6 277 1.2× 20 0.7× 39 1.3× 25 0.9× 29 1.3× 7 354
Astrid N L Hermans Netherlands 12 283 1.2× 7 0.2× 17 0.6× 23 0.8× 23 1.0× 30 362
Pedro Magalhães Brazil 9 124 0.5× 5 0.2× 39 1.3× 12 0.4× 16 0.7× 24 215
David K. Tan United States 7 67 0.3× 9 0.3× 29 1.0× 7 0.3× 7 0.3× 21 167
Laura Burgess United Kingdom 6 78 0.3× 14 0.5× 46 1.5× 52 1.9× 5 0.2× 10 251
Mayank Dalakoti Singapore 11 140 0.6× 10 0.3× 39 1.3× 19 0.7× 23 1.0× 34 258
Anna Ramos‐Pachón Spain 7 70 0.3× 27 0.9× 82 2.7× 30 1.1× 28 1.3× 15 182
Scott Wehrenberg United States 6 210 0.9× 4 0.1× 13 0.4× 25 0.9× 16 0.7× 13 338

Countries citing papers authored by Ramón Bover

Since Specialization
Citations

This map shows the geographic impact of Ramón Bover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramón Bover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramón Bover more than expected).

Fields of papers citing papers by Ramón Bover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramón Bover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramón Bover. The network helps show where Ramón Bover may publish in the future.

Co-authorship network of co-authors of Ramón Bover

This figure shows the co-authorship network connecting the top 25 collaborators of Ramón Bover. A scholar is included among the top collaborators of Ramón Bover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramón Bover. Ramón Bover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vicent, Lourdes, Jesús Álvarez‐García, Rafael Vázquez, et al.. (2023). Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction. Journal of Clinical Medicine. 12(8). 3028–3028. 4 indexed citations
2.
Sequera, Patricia de, et al.. (2023). Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain. Nefrología (English Edition). 43(6). 721–730.
3.
Esteban‐Fernández, Alberto, et al.. (2023). Ferric carboxymaltose for patients with heart failure in all-range ejection fraction. REC CardioClinics. 58(4). 281–288.
4.
Esteban‐Fernández, Alberto, Lourdes Vicent, Pablo Díez‐Villanueva, et al.. (2022). Impacto de la presión arterial en el tratamiento y pronóstico de los pacientes tratados con sacubitrilo/valsartán. REC CardioClinics. 57(2). 116–122. 1 indexed citations
5.
Vicent, Lourdes, María José Guerra Palmero, Rafael Vázquez, et al.. (2021). Ischemic Etiology and Prognosis in Men and Women with Acute Heart Failure. Journal of Clinical Medicine. 10(8). 1713–1713. 7 indexed citations
6.
Vicent, Lourdes, Jesús Álvarez‐García, José Ramón González‐Juanatey, et al.. (2020). Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid‐range and reduced ejection fraction. Internal Medicine Journal. 51(6). 930–938. 11 indexed citations
7.
López‐Azor, Juan Carlos, Lourdes Vicent, Alberto Esteban‐Fernández, et al.. (2019). Safety of Sacubitril/Valsartan Initiated During Hospitalization: Data from a Non-Selected Cohort. ESC Heart Failure. 6(6). 1161–1166. 20 indexed citations
8.
Esteban‐Fernández, Alberto, Pablo Díez‐Villanueva, Lourdes Vicent, et al.. (2019). Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort. Revista Española de Geriatría y Gerontología. 55(2). 65–69. 18 indexed citations
9.
10.
Barrios, Vivencio, Carlos Escobar, Vicente Pallarés‐Carratalá, et al.. (2018). Programa MICCAP (Manejo de la Insuficiencia Cardiaca en Cardiología y en Atención Primaria): mejorando el manejo del paciente con insuficiencia cardiaca. Medicina de Familia SEMERGEN. 44(8). 572–578. 4 indexed citations
11.
Skobel, Erik, Christian Knackstedt, Dario Salvi, et al.. (2016). Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels. 32(4). 408–418. 61 indexed citations
12.
Subirana, María Teresa, Gonzalo Barón‐Esquivias, Nicolás Manito, et al.. (2014). Actualización 2013 en cardiopatías congénitas, cardiología clínica e insuficiencia cardiaca y trasplante. Revista Española de Cardiología. 67(3). 211–217. 3 indexed citations
13.
García, Ana María Pérez, et al.. (2013). Subjective Well-being in Heart Failure Patients: Influence of Coping and Depressive Symptoms. International Journal of Behavioral Medicine. 21(2). 258–265. 31 indexed citations
14.
Ramos‐Leví, Ana M., José A. Díaz-Pérez, Carmen Povés, & Ramón Bover. (2011). Tumor carcinoide y foramen oval permeable. Endocrinología y Nutrición. 58(4). 206–209.
15.
Ten, J. I., et al.. (2010). Can Information Technology Improve the Performance of Remote Monitoring Systems?. Telemedicine Journal and e-Health. 16(9). 977–979. 1 indexed citations
16.
Bover, Ramón, et al.. (2009). Long-term Follow-up of Atrial Fibrillation Patients in the NASPEAF Study. Prospective Evaluation of Different Antiplatelet Treatments. Revista Española de Cardiología (English Edition). 62(9). 992–1000. 6 indexed citations
17.
Pérez-Gómez, Francisco, J.A. Iriarte, Jesús Berjón, et al.. (2006). Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial. European Heart Journal. 28(8). 996–1003. 22 indexed citations
18.
Bover, Ramón, et al.. (2006). Supresión de arritmias supraventriculares y ventriculares. ¿Qué papel pueden desempeñar los ácidos grasos omega-3?. Revista Española de Cardiología. 6(Supl.D). 38–51. 1 indexed citations
19.
Pérez-Gómez, Francisco, Antonio Salvador, J.A. Iriarte, et al.. (2005). Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial. European Heart Journal. 27(8). 960–967. 30 indexed citations
20.
Pérez‐Villacastín, Julián, et al.. (2004). Estratificación del riesgo y prevención de la muerte súbita en pacientes con insuficiencia cardíaca. Revista Española de Cardiología. 57(8). 768–782. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan M. Streur Breakdown of academic impact, for papers by Pieter Koopman Breakdown of academic impact, for papers by Leonard Sheung-Wai Li Breakdown of academic impact, for papers by Astrid N L Hermans Breakdown of academic impact, for papers by Pedro Magalhães Breakdown of academic impact, for papers by David K. Tan Breakdown of academic impact, for papers by Laura Burgess Breakdown of academic impact, for papers by Mayank Dalakoti Breakdown of academic impact, for papers by Anna Ramos‐Pachón Breakdown of academic impact, for papers by Scott Wehrenberg
Rankless by CCL
2026